- A J****
kinase inhibitor, also
known as JAK
inhibitor or
jakinib, is a type of
immune modulating medication,
which inhibits the
activity of one or more...
-
released warnings about the risk of
blood clots. An
important side
effect of
Jakinibs is
serious bacterial, mycobacterial,
fungal and
viral infections. In the...
-
overlapping receptor responsibilities.
Inhibitors of this
enzyme family (
jakinibs) have
shown efficacy in
treating certain inflammatory and
autoimmune diseases...
- Cunningham-Rundles, Charlotte; Eckstein, Olive; Olbrich,
Peter (November 2018). "
Jakinibs for the
treatment of
immune dysregulation in
patients with gain-of-function...
-
received a method-of-use
patent in 2018 to
repurpose a
family of drugs, the
Jakinibs, for use in ALS
treatment based on her data
identifying a
novel mechanism...
-
Bettanin BF,
Majolo F,
Gehringer M,
Laufer S, et al. (June 2021). "Current
jakinibs for the
treatment of
rheumatoid arthritis: a
systematic review". Inflammopharmacology...
